메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
출처
Elsevier BV JAAD Case Reports 40
오류 신고하기
표지

검색

    초록·키워드

    Reactive granulomatous dermatitis (RGD) may occur in response to a variety of underlying etiologies, including autoimmune conditions, medications, and malignancy. Rarely, RGD may be a presenting sign of myelodysplastic syndrome or myeloid leukemia, and recognition of this cutaneous manifestation is essential so that patients can be evaluated and treated accordingly.1 The treatment of RGD centers around managing the underlying condition, although other treatments, including topical/oral corticosteroids, hydroxychloroquine, tetracycline antibiotics, methotrexate, cyclosporine, dapsone, and tumor necrosis factor-α inhibitors have been utilized with varying efficacy.

    본문·목차

    최근 본 자료 전체보기